Associated Papers
From Rare to Common: Genetic Insights into TLR7 Variants in a Multicentric Spanish Study on COVID-19 Severity.
Antolí A et al.
Journal of Clinical Immunology, 2025
Systematic assessment of COVID-19 host genetics using whole genome sequencing data.
Schmidt A et al.
Plos Pathogens, 2024
39715278 (PubMed )
Supplement: ppat.1012786.s013.xlsx › Tabelle1
The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants.
Naushad SM et al.
Scientific Reports, 2023
TLRs: Innate Immune Sentries against SARS-CoV-2 Infection.
Mantovani S et al.
International Journal of Molecular Sciences, 2023
Host genetic basis of COVID-19: from methodologies to genes.
Zguro K et al.
European Journal of Human Genetics : Ejhg, 2022
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients.
Mantovani S et al.
Genes and Immunity, 2022
Human genetic basis of coronavirus disease 2019.
Deng H et al.
Signal Transduction and Targeted Therapy, 2021
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Asano T et al.
Science Immunology, 2021
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study.
Fallerini C et al.
Elife, 2021
Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19.
Solanich X et al.
Frontiers in Immunology, 2021
Clinical and Genetic Analysis of CHD7 Expands the Genotype and Phenotype of CHARGE Syndrome.
Qin Z et al.
Frontiers in Genetics, 2020
32625235 (PubMed )
Supplement: Data_Sheet_1.zip › Supplementary_Table_2.XLSX › patient_1
Select a paper to view details